Luc Mainville

Mr. Luc Mainville is a Chief Financial Officer & Senior Vice President at ChitogenX, Inc., a President at LUMA Life, Inc. and a Chief Financial Officer & Senior Vice President at LSL Pharma Group, Inc. Mr. Mainville was previously employed as a Chief Financial Officer & Senior Vice President by Valeo Pharma, Inc., a Chairman by Zucara Therapeutics, Inc., a Senior Vice President by Cardiome Pharma Corp., a President & Chief Executive Officer by Neopharm Labs, Inc., a Vice Chairman by BIOTECanada, a President, Chief Executive Officer & Director by LAB Research, Inc., a Chairman by BioAxone Therapeutic, Inc., a Chairman by Power Tech Corp., Inc., a Chief Financial & Operating Officer by LAB International, Inc., a CFO, Vice President-Finance & Administration by URRMA Biopharma, Inc., a CFO, Vice President-Finance & Administration by Waratah Pharmaceuticals, Inc., a Chief Financial Officer by RTP Pharma, Inc, a SVP & Partner-Corporate Finance Group by KPMG LLP, a Founder by LUMA Capital LLC, and a Principal by Manitex Capital, Inc. He also served on the board at Acerus Pharmaceuticals Corp., Alethia Biotherapeutics, Inc., Compass Biotechnologies, Inc., AAA Medic Montreal, Inc. and Enobia Pharma, Inc. He received his undergraduate degree from the University of Quebec and an MBA from McGill University.